Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery
- 1 March 1999
- journal article
- Published by Wiley in Haemophilia
- Vol. 5 (2), 96-100
- https://doi.org/10.1046/j.1365-2516.1999.t01-1-00284.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical proceduresHaemophilia, 1997
- THE EFFECT OF TRANEXAMIC ACID ON LOCAL AND PLASMA FIBRINOLYSIS DURING TOTAL KNEE ARTHROPLASTYThrombosis Research, 1997
- Coagulation factor concentrates by continuous infusionTransfusion Medicine Reviews, 1997
- Current strategy for genetic analysis of haemophilia A familiesHaemophilia, 1996
- The feasibility of using concentrates containing factor IX for continuous infusionHaemophilia, 1995
- Treatment with a pure factor IX concentrate in a patient with moderate hemophilia B undergoing bilateral total hip replacementTransfusion, 1993
- Treatment of hemophilia b: Serendipitous use of continuous infusion coagulation factor IXThrombosis Research, 1993